Orthobiologics Market
Analysts’ Viewpoint
Increase in incidence of bone diseases is expected to drive the global orthobiologics market during the forecast period. Introduction of new products with advanced technology by various companies contributes to market expansion. Rise in healthcare spending and surge in awareness about the benefits of early detection and treatment of bone diseases are likely to propel industry development. Furthermore, increase in adoption of bone grafts, such as allografts and xenografts, and concentration of platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and others in emerging economies are fueling market progress.
Merger & acquisition and increase in investment in orthobiologics offer lucrative opportunities for market players. Companies are focusing on development of advanced and cost-effective orthobiologics in order to increase market share and presence.
Orthobiologics refer to a group of medical treatments that use biological materials, such as cells, tissues, and growth factors, to enhance the healing process of bone and soft tissue injuries. Regenerative medicines are typically used to improve the healing of musculoskeletal injuries, including fractures, ligament & tendon tears, and cartilage damage.
Platelet-rich plasma (PRP) therapy involves injecting a concentrated solution of a patient's own platelets, which are rich in growth factors, into an injured area to promote tissue regeneration and healing. Stem cell therapy involves using a patient's own stem cells or donor stem cells to regenerate damaged tissues. Bone grafting is the transplantation of bone tissue from one part of the body or a donor to a damaged area to stimulate bone growth and healing. Cartilage regeneration involves the usage of scaffolds or implants to promote the growth of new cartilage tissue in areas where it has been damaged or lost.
Orthobiologics are often used in conjunction with traditional orthopedic treatments, such as surgery and physical therapy, to help improve the healing process and reduce recovery time, regenerative medicines, and musculoskeletal injuries.
Sports injuries are common among athletes and individuals who engage in physical activities. These injuries range from mild strains and sprains to more severe injuries such as fractures and ligament tears. Orthobiologics, which include biological substances such as stem cells, growth factors, and platelet-rich plasma, has emerged as a promising treatment option for sports injuries.
The rise in the prevalence of sports injuries is one of the key drivers of the orthobiologics market. According to a report by the American Academy of Orthopaedic Surgeons (AAOS), sports injuries account for around 8.6 million visits to emergency departments in the U.S. each year. Common sports injuries include sprains and strains, which involve damage to the ligaments and muscles, and fractures. These injuries can be caused by a range of factors, including overuse, poor technique, and accidents.
Orthobiologics offer several advantages over traditional treatment options for sports injuries. For example, stem cells have the ability to differentiate into different types of cells and can promote tissue regeneration and repair. Platelet-rich plasma (PRP) contains growth factors that can stimulate the healing process and reduce inflammation. These biological substances can be injected directly into the site of injury, promoting faster healing and reducing the need for invasive surgery.
Several studies have demonstrated the effectiveness of orthobiologics in treating sports injuries. For example, a study published in the Journal of Orthopedic Research revealed that PRP injections improved the healing of Achilles tendon injuries in rats. Another study published in the American Journal of Sports Medicine indicated that the use of stem cells in the treatment of knee injuries resulted in improved function and pain relief.
According to the CDC, approximately 1.5 million sports and recreation-related traumatic brain injuries (TBIs) were treated in the U.S. emergency departments in 2018. The National Safety Council (NSC) reported that sports-related injuries are the second leading cause of emergency department visits for children and adolescents aged 5-19 years in the U.S. The most common types of sports injuries are sprains and strains, which account for about 40% of all sports injuries. Fractures make up about 10% of all sports injuries.
A collection of musculoskeletal conditions known as chronic arthritis involve joint inflammation and destruction, resulting in pain, stiffness, and decreased mobility. There are different types of arthritis; the two most prevalent are osteoarthritis and rheumatoid arthritis. All ages and genders can develop arthritis, although older persons and women are more likely to develop it than other groups.
According to the Centers for Disease Control and Prevention (CDC), an estimated 54.4 million adults in the U.S., or 22.7% of the population, have some form of arthritis. The prevalence of arthritis increases with age, with an estimated 49.6% of adults aged 65 years and older reporting arthritis. Arthritis is also more common in women than men, with an estimated 26.2% of women and 20.7% of men reporting arthritis.
According to the World Health Organization (WHO), an estimated 10% to 15% of the world's population is affected by arthritis. This equates to around 700 million to 1 billion people worldwide. The prevalence of arthritis varies by region and is influenced by factors such as age, genetics, lifestyle, and environmental factors.
Arthritis is a leading cause of disability globally, affecting individuals' ability to perform daily activities, work, and participate in social and recreational activities. The economic burden of arthritis is also significant, with direct medical costs and lost productivity estimated to be billions of dollars annually.
Rise in prevalence of chronic arthritis is driving the global orthobiologics market. Orthobiologics are biological substances that can be used to enhance the healing process of musculoskeletal injuries or disorders. These substances can be derived from natural sources such as bone, cartilage, or blood, or can be produced synthetically. Orthobiologics offer a less invasive option for treating chronic arthritis and other musculoskeletal disorders.
In terms of product, the global orthobiologics market has been classified into allografts, xenografts, synthetic bone grafts, demineralized bone matrix (DBM), viscosupplementation, platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and others. The viscosupplementation segment dominated the global market in 2022. Viscosupplementation refers to the injection of hyaluronic acid (HA) into the joint space to provide lubrication and cushioning for the affected joint.
Based on application, the global orthobiologics market has been segregated into spinal fusion, trauma repair, reconstructive surgeries, fractures, osteoarthritis, maxillofacial and dental applications, and others. The spinal fusion segment accounted for major share of the global market in 2022. Usage of orthobiologics in spinal fusion procedures has become increasingly common in the past few years, as these have been shown to improve the outcome of these procedures and reduce the need for additional surgeries.
As per orthobiologics market trends, North America accounted for major share of the global market in 2022. The market in the region is likely to expand at a high CAGR from 2023 to 2031. This is ascribed to surge in prevalence of orthopedic disorders and injuries. According to the CDC, an estimated 54 million adults have been diagnosed with some form of arthritis in the U.S. alone, and this number is expected to rise to 78 million by 2040. Increase in incidence of orthopedic disorders is driving the demand for orthobiologic products, including bone graft substitutes, which are used in procedures, such as spinal fusion and joint reconstruction.
Asia Pacific is expected to be the fastest growing market for orthobiologics during the forecast period. This is ascribed to aging population, rise in prevalence of musculoskeletal disorders, and increase in demand for minimally invasive surgical procedures.
The global market is fragmented, with the presence of large number of local as well as international players. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by the leading players. Alphatec Spine, Inc., Arthrex, Bioventus, Inc., Exactech, Inc., Global Medical, Inc., Integra Lifesciences, Medtronic, MTF Biologics, RTI Surgical, Sano Orthopedics, Sanofi, Seikagaku Corporation, Stryker, and Zimmer Biomet are the prominent players in the global orthobiologics market.
Each of these players has been profiled in the orthobiologics market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2022 |
US$ 8.4 Bn |
|
Forecast (Value) in 2031 |
US$ 13.8 Bn |
|
Growth Rate (CAGR) |
5.5% |
|
Forecast Period |
2023–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 8.4 Bn in 2022
It is projected to reach more than US$ 13.8 Bn by 2031
The CAGR is anticipated to be 5.5% from 2023 to 2031.
Surge in sports injuries and rise in prevalence of chronic arthritis are driving the global market.
North America is expected to account for the largest share of the global market during the forecast period.
Alphatec Spine, Inc., Arthrex, Bioventus LLC, Exactech, Inc., Global Medical, Inc., Integra Lifesciences, Medtronic, MTF Biologics, RTI Surgical, Sano Orthopedics, Sanofi, Seikagaku Corporation, Stryker, and Zimmer Biomet are the prominent players in the market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Orthobiologics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Orthobiologics Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Market Trends
5.2. Merger & Acquisition
5.3. Strategies of Top Five Players Operating in the Market
5.4. Incidence of Orthopedic Disorder, by Key Countries
5.5. Number of Surgical Procedures
5.6. Regulatory and Reimbursement Scenario by Key Countries
5.7. Covid-19 Pandemic Impact on the Industry
6. Global Orthobiologics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. Allografts
6.3.2. Xenografts
6.3.3. Synthetic Bone Grafts
6.3.3.1. Hydroxyapatite
6.3.3.2. β-tricalcium Phosphate (β-TCP)
6.3.3.3. BiPhasic
6.3.3.4. Bioactive Glass
6.3.3.5. Others
6.3.4. Demineralized Bone Matrix (DBM)
6.3.5. Viscosupplementation
6.3.6. Platelet-rich Plasma (PRP)
6.3.7. Bone Marrow Aspirate Concentrate (BMAC)
6.3.8. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Orthobiologics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Spinal Fusion
7.3.2. Trauma Repair
7.3.3. Reconstructive Surgeries
7.3.4. Fractures
7.3.5. Osteoarthritis
7.3.6. Maxillofacial & Dental Applications
7.3.7. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Orthobiologics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Orthopedic Clinics
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Orthobiologics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Orthobiologics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
10.2.1. Allografts
10.2.2. Xenografts
10.2.3. Synthetic Bone Grafts
10.2.3.1. Hydroxyapatite
10.2.3.2. β-tricalcium Phosphate (β-TCP)
10.2.3.3. BiPhasic
10.2.3.4. Bioactive Glass
10.2.3.5. Others
10.2.4. Demineralized Bone Matrix (DBM)
10.2.5. Viscosupplementation
10.2.6. Platelet-rich Plasma (PRP)
10.2.7. Bone Marrow Aspirate Concentrate (BMAC)
10.2.8. Others
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Spinal Fusion
10.3.2. Trauma Repair
10.3.3. Reconstructive Surgeries
10.3.4. Fractures
10.3.5. Osteoarthritis
10.3.6. Maxillofacial & Dental Applications
10.3.7. Others
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Orthopedic Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Orthobiologics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. Allografts
11.2.2. Xenografts
11.2.3. Synthetic Bone Grafts
11.2.3.1. Hydroxyapatite
11.2.3.2. β-tricalcium Phosphate (β-TCP)
11.2.3.3. BiPhasic
11.2.3.4. Bioactive Glass
11.2.3.5. Others
11.2.4. Demineralized Bone Matrix (DBM)
11.2.5. Viscosupplementation
11.2.6. Platelet-rich Plasma (PRP)
11.2.7. Bone Marrow Aspirate Concentrate (BMAC)
11.2.8. Others
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Spinal Fusion
11.3.2. Trauma Repair
11.3.3. Reconstructive Surgeries
11.3.4. Fractures
11.3.5. Osteoarthritis
11.3.6. Maxillofacial & Dental Applications
11.3.7. Others
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Orthopedic Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Orthobiologics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. Allografts
12.2.2. Xenografts
12.2.3. Synthetic Bone Grafts
12.2.3.1. Hydroxyapatite
12.2.3.2. β-tricalcium Phosphate (β-TCP)
12.2.3.3. BiPhasic
12.2.3.4. Bioactive Glass
12.2.3.5. Others
12.2.4. Demineralized Bone Matrix (DBM)
12.2.5. Viscosupplementation
12.2.6. Platelet-rich Plasma (PRP)
12.2.7. Bone Marrow Aspirate Concentrate (BMAC)
12.2.8. Others
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Spinal Fusion
12.3.2. Trauma Repair
12.3.3. Reconstructive Surgeries
12.3.4. Fractures
12.3.5. Osteoarthritis
12.3.6. Maxillofacial & Dental Applications
12.3.7. Others
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Orthopedic Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Orthobiologics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. Allografts
13.2.2. Xenografts
13.2.3. Synthetic Bone Grafts
13.2.3.1. Hydroxyapatite
13.2.3.2. β-tricalcium Phosphate (β-TCP)
13.2.3.3. BiPhasic
13.2.3.4. Bioactive Glass
13.2.3.5. Others
13.2.4. Demineralized Bone Matrix (DBM)
13.2.5. Viscosupplementation
13.2.6. Platelet-rich Plasma (PRP)
13.2.7. Bone Marrow Aspirate Concentrate (BMAC)
13.2.8. Others
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Spinal Fusion
13.3.2. Trauma Repair
13.3.3. Reconstructive Surgeries
13.3.4. Fractures
13.3.5. Osteoarthritis
13.3.6. Maxillofacial & Dental Applications
13.3.7. Others
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Orthopedic Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Orthobiologics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
14.2.1. Allografts
14.2.2. Xenografts
14.2.3. Synthetic Bone Grafts
14.2.3.1. Hydroxyapatite
14.2.3.2. β-tricalcium Phosphate (β-TCP)
14.2.3.3. BiPhasic
14.2.3.4. Bioactive Glass
14.2.3.5. Others
14.2.4. Demineralized Bone Matrix (DBM)
14.2.5. Viscosupplementation
14.2.6. Platelet-rich Plasma (PRP)
14.2.7. Bone Marrow Aspirate Concentrate (BMAC)
14.2.8. Others
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Spinal Fusion
14.3.2. Trauma Repair
14.3.3. Reconstructive Surgeries
14.3.4. Fractures
14.3.5. Osteoarthritis
14.3.6. Maxillofacial & Dental Applications
14.3.7. Others
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Orthopedic Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share/Ranking Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Alphatec Spine, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Arthrex
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Bioventus LLC
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Exactech, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Global Medical, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Integra Lifesciences
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Medtronic
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. MTF Biologics
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. RTI Surgical
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Sano Orthopedics
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Sanofi
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Strategic Overview
15.3.12. Seikagaku Corporation
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Strategic Overview
15.3.13. Stryker
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Strategic Overview
15.3.14. Zimmer Biomet
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Strategic Overview
List of Tables
Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by 2017‒2031, by Application
Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Orthobiologics Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 07: North America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 08: North America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 15: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 16: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 19: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 20: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 23: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 24: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Orthobiologics Market Value Share, by Product, 2021
Figure 03: Global Orthobiologics Market Value Share, by Application, 2021
Figure 04: Global Orthobiologics Market Value Share, by End-user, 2021
Figure 05: Global Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 06: Global Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031
Figure 07: Global Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 08: Global Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031
Figure 09: Global Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 10: Global Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 11: Global Orthobiologics Market Value Share Analysis, by Region, 2021 and 2031
Figure 12: Global Orthobiologics Market Attractiveness Analysis, by Region, 2023–2031
Figure 13: North America Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031
Figure 14: North America Orthobiologics Market Value Share Analysis, by Country, 2021 and 2031
Figure 15: North America Orthobiologics Market Attractiveness Analysis, by Country, 2023–2031
Figure 16: North America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 17: North America Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031
Figure 18: North America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 19: North America Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031
Figure 20: North America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 21: North America Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 22: Europe Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031
Figure 23: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 24: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 25: Europe Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 26: Europe Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031
Figure 27: Europe Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 28: Europe Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031
Figure 29: Europe Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 30: Europe Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 31: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031
Figure 32: Asia Pacific Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 33: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 34: Asia Pacific Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 35: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031
Figure 36: Asia Pacific Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 37: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031
Figure 38: Asia Pacific Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 39: Asia Pacific Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 40: Latin America Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031
Figure 41: Latin America Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 42: Latin America Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 43: Latin America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 44: Latin America Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031
Figure 45: Latin America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 46: Latin America Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031
Figure 47: Latin America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 48: Latin America Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 49: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031
Figure 50: Middle East & Africa Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 51: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 52: Middle East & Africa Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 53: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031
Figure 54: Middle East & Africa Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 55: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031
Figure 56: Middle East & Africa Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 57: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 58: Company Share Analysis, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes